Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood test.

Teunissen, Charlotte E; Thijssen, Elisabeth H; Verberk, Inge M W · Brain · 2020

editorial · Level V

Where this comes from

Abstract

This scientific commentary refers to ‘Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease’, by Mattsson-Carlgren <i>et al.</i> (doi:10.1093/brain/awaa286).

Medical subject headings